Mucinous cystadenocarcinoma natural history: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (13 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Mucinous cystadenocarcinoma}} | {{Mucinous cystadenocarcinoma}} | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Qurrat}}, {{Ammu}} | ||
==Overview== | ==Overview== | ||
If left untreated, most of the [[Patient|patients]] with mucinous cystadenocarcinoma may be confined to the [[Organ (anatomy)|organ]] itself. Common [[Complication (medicine)|complications]] of mucinous cystadenocarcinoma include [[metastasis]] and [[inguinal hernia]]. The presence of [[metastasis]] is associated with a particularly poor [[prognosis]] among [[Patient|patients]] with mucinous cystadenocarcinoma. | |||
==Natural History, Complications, and Prognosis== | |||
==Natural History== | === Natural History === | ||
* If left untreated, most of patients with mucinous | * If left untreated, most of the [[Patient|patients]] with mucinous cystadenocarcinoma may be confined to the [[Organ (anatomy)|organ]] itself. | ||
==Complications== | * Some of them may develop [[metastasis]] to the [[gastrointestinal tract]].<ref name="Guruprasad2012">{{cite journal|last1=Guruprasad|first1=Bhat|title=Mucinous cystadenocarcinoma of ovary: Changing treatment paradigms|journal=World Journal of Obstetrics and Gynecology|volume=1|issue=4|year=2012|pages=42|issn=2218-6220|doi=10.5317/wjog.v1.i4.42}}</ref> | ||
* Metastasis | ===Complications=== | ||
==Prognosis== | * Common [[Complication (medicine)|complications]] of mucinous cystandenocarcinoma are: | ||
* | :* [[Metastasis]] | ||
:* [[Inguinal hernia]] | |||
===Prognosis=== | |||
* Mucinous cystadenocarcinoma has a much more favorable [[prognosis]] than most other forms of [[adenocarcinoma]]. | |||
* Advanced [[Cancer staging|stages]] of mucinous cystadenocarcinoma have an inferior [[prognosis]]. | |||
* 5-year [[Survival analysis|survival]] has been stated to be approximately 50% when treated with cytoreduction (debulking) [[surgery]] to remove all of the [[tumor]]<nowiki/>[[tumor|s]] in the [[abdomen]] which is combined with hyperthermic intraoperative [[peritoneal]] [[chemotherapy]] (HIPEC). | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 17: | Line 23: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Oncology]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category: | [[Category:Oncology]] | ||
[[Category:Medicine]] | |||
Latest revision as of 15:59, 17 September 2019
|
Mucinous cystadenocarcinoma Microchapters |
|
Differentiating Mucinous Cystadenocarcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mucinous cystadenocarcinoma natural history On the Web |
|
American Roentgen Ray Society Images of Mucinous cystadenocarcinoma natural history |
|
Directions to Hospitals Treating Mucinous cystadenocarcinoma |
|
Risk calculators and risk factors for Mucinous cystadenocarcinoma natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Ammu Susheela, M.D. [3]
Overview
If left untreated, most of the patients with mucinous cystadenocarcinoma may be confined to the organ itself. Common complications of mucinous cystadenocarcinoma include metastasis and inguinal hernia. The presence of metastasis is associated with a particularly poor prognosis among patients with mucinous cystadenocarcinoma.
Natural History, Complications, and Prognosis
Natural History
- If left untreated, most of the patients with mucinous cystadenocarcinoma may be confined to the organ itself.
- Some of them may develop metastasis to the gastrointestinal tract.[1]
Complications
- Common complications of mucinous cystandenocarcinoma are:
Prognosis
- Mucinous cystadenocarcinoma has a much more favorable prognosis than most other forms of adenocarcinoma.
- Advanced stages of mucinous cystadenocarcinoma have an inferior prognosis.
- 5-year survival has been stated to be approximately 50% when treated with cytoreduction (debulking) surgery to remove all of the tumors in the abdomen which is combined with hyperthermic intraoperative peritoneal chemotherapy (HIPEC).
References
- ↑ Guruprasad, Bhat (2012). "Mucinous cystadenocarcinoma of ovary: Changing treatment paradigms". World Journal of Obstetrics and Gynecology. 1 (4): 42. doi:10.5317/wjog.v1.i4.42. ISSN 2218-6220.